Diversity in Alzheimer's disease drug trials: Reflections on reporting and social construction of race.
- DOI
- 10.1002/alz.12611
- Published
- 2022 Apr
- Container
- Alzheimer's & dementia : the journal of the Alzheimer's Association
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/alz.12611,
title = {Diversity in Alzheimer's disease drug trials: Reflections on reporting and social construction of race.},
author = {Babulal GM and Franzen S and Abner EL and Smith JE and van den Berg E and Mindt MR and van Bruchem-Visser RL and Schneider LS and Prins ND and Papma JM},
year = {2022},
journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
doi = {10.1002/alz.12611},
url = {https://doi.org/10.1002/alz.12611}
}RIS
TY - JOUR TI - Diversity in Alzheimer's disease drug trials: Reflections on reporting and social construction of race. AU - Babulal GM AU - Franzen S AU - Abner EL AU - Smith JE AU - van den Berg E AU - Mindt MR AU - van Bruchem-Visser RL AU - Schneider LS AU - Prins ND AU - Papma JM PY - 2022 JO - Alzheimer's & dementia : the journal of the Alzheimer's Association DO - 10.1002/alz.12611 UR - https://doi.org/10.1002/alz.12611 ER -
APA
GM, B., S, F., EL, A., JE, S., E, V. D. B., MR, M., RL, V. B., LS, S., ND, P., & JM, P. (2022). Diversity in Alzheimer's disease drug trials: Reflections on reporting and social construction of race.. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.12611
Source records
- pubmed · retrieved 2026-09-26T07:05:12.731Z